跳至主要内容
临床试验/NL-OMON45195
NL-OMON45195尚未招募2 期

Prospective randomized multicenter comparison of indocyanine green (ICG)-99mTc-nanocolloid vs. 99mTc-nanocolloid plus an intraoperative injection of ICG for the detection and surgical resection of the sentinel nodes in patients with prostate cancer - Free vs nanocolloid bound ICG for prostate sentinel node

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Histologically proven prostate cancer;
  • Patients are clinically node negative and metastases negative (N0, M0);
  • Increased risk of nodal metastases according to the Briganti nomogram (> 7%);
  • Scheduled for surgical (laparoscopic or robotic) prostatectomy including nodal dissection.

排除标准

  • History of iodine allergy;
  • Hyperthyroid or thyroidal adenoma;
  • Kidney insufficiency.

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验

Prospective randomized multicenter comparison of... | 临床试验